Search Results Search Sort by RelevanceMost Recent Art of Medicine Jun 2020 On Seeing and Being Seen in Dementia Care Kathryn Hominick, MSW There’s similarity between processes used by an artist to see the entirety of a scene and those used by a clinician to assess a patient. AMA J Ethics. 2020;22(6):E550-556. doi: 10.1001/amajethics.2020.550. Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 1 Hasan Shanawani, MD, MPH Virtual Mentor. 2005;7(7):469-473. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507. Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 2 Kathleen Nathan Lowe, MSW, ACSW, CMSW Virtual Mentor. 2005;7(7):473-475. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Art of Medicine Jun 2020 On Seeing and Being Seen in Dementia Care Kathryn Hominick, MSW There’s similarity between processes used by an artist to see the entirety of a scene and those used by a clinician to assess a patient. AMA J Ethics. 2020;22(6):E550-556. doi: 10.1001/amajethics.2020.550.
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 1 Hasan Shanawani, MD, MPH Virtual Mentor. 2005;7(7):469-473. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507.
Case and Commentary Jul 2005 Is Greenacres (Skilled Nursing Facility) the Place to Be? Commentary 2 Kathleen Nathan Lowe, MSW, ACSW, CMSW Virtual Mentor. 2005;7(7):473-475. doi: 10.1001/virtualmentor.2005.7.7.ccas3-0507.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411.